A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
A phase 2 trial of Cisplatin, Gemcitabine and Bevacizumab in advanced solid tumours, run by Nanjing Leads Biolabs Co.,Ltd, now recruiting.
Overview
A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)] is a phase 2 interventional study registered as NCT07111546 by Nanjing Leads Biolabs Co.,Ltd, with 140 participants planned, started 2025-10-20 and due to reach its primary completion in 2027-12-26. Interventions recorded: LBL-024 for Injection, Cisplatin Injection, Gemcitabine Hydrochloride for Injection and Bevacizumab Injection.
Similar pages
not linked directly; found by shared links- TrialA Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors
Shares Nanjing Leads Biolabs, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]
Shares Nanjing Leads Biolabs, Cisplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]
Shares Nanjing Leads Biolabs, Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialCosiporfin Sodium for Injection Photodynamic Therapy
Shares Gemcitabine, Cisplatin and the tag pipeline.
- TrialA Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
Shares Gemcitabine, Cisplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
Shares Nanjing Leads Biolabs and the tag pipeline.
- TrialSHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer
Shares Gemcitabine, Bevacizumab, Cisplatin and the tag pipeline.
- TrialA Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
Shares Nanjing Leads Biolabs, Metastatic cancer (cancer that has spread) and the tag pipeline.